The greedy jerk bought $1.7 million in pharmaceutical stock right before Republican legislation forced the price up, and the jackass made $55 million.
Trump investments benefited from exemptions
Investments in pharmaceutical companies made by President Donald Trump increased significantly after he returned to the White House last year, with his portfolio adding millions of dollars in stock in firms that benefited from a Republican-backed law that shields certain medications from Medicare price negotiations.
The report, released Friday by the Joint Economic Committee’s minority arm, found that Trump’s pharmaceutical stock holdings grew from a maximum reported value of $1.7 million in 2024 to $56.2 million at the end of 2025., and are higher today.
The report said that included $39.1 million of stock held in companies that benefited from exemptions to Medicare’s drug price negotiation program, which came through a provision in Republicans’ 2025 tax and spending law that forces us all to pay more for necessary medications.
Comments